New in 2019!

Transporter Workshop, organized by The Boston Society

April 11th, 2019

Novartis Institutes for Biomedical Research Auditorium 
250 Massachusetts Ave 
Cambridge, MA 02139

 

 

Join us for the Ninth Annual HT-ADME Conference!

HT-ADME 2019 

June 20th, 2019

Merck 
33 Avenue Louis Pasteur 
Boston, MA 02115

 

 

 

Click to Download the HT-ADME 2018 Program Guide

Plenary Speaker

 

Jashvant (Jash) Unadkat, Milo Gibaldi Endowed Professor, Department of Pharmaceutics; Director, UW Research Affiliates Program on Transporters, University of Washington School of Pharmacy

Pursuing the Holy Grail of Predicting and Verifying Tissue Drug Concentrations:  A Proteomics and PET Imaging Approach

     

 

Invited Speakers 

 

Nagendra Chemuturi, Senior Investigator I, Ophthalmology TA, Novartis Institutes for Biomedical Research

ADME Characterization of Antibody Drug Conjugates

            

Sean Kim, Director of DMPK, Blueprint Medicines

Incorporating Human Dose Projection in Early Lead Optimization; Good or Bad Idea?

               
 

Murat Cirit, Director of the Translational Center of Tissue Chip Technologies at Massachusetts Institute of Technology (MIT)

Translational DMPK Applications of Tissue Chip Technologies

            

Kenneth Koeplinger, Research Fellow, Merck 

Pharmacologic Target Validation  Utilizing siRNA-Mediated Knock Down of Hepatic Genes

               
 

Sujal Deshmukh, Senior Investigator II at Novartis Institutes for BioMedical Research

Adapting and Readapting in the  Outsourcing Era

            

Stefan Linehan, Director of Innovation and Outsourcing at Blue Tail Regenerative Therapeutics

Mass Spectrometry Imaging: Revealing Tissue Secrets for Early Drug Efficacy and Risk Assessment

               
 

Adam Gilbert, Senior Director, Medicinal Chemistry, Pfizer

ADME Implications of Chimeric Protein Degrader Druggability

       

Marina Slavsky, Senior Scientist, Sanofi Genzyme

High Content Metabolic Stability Assay for Drug Discovery

 

               
 

Elizabeth Joshi, Principal Scientist, Merck

Leveraging in silico ADMET Models and Influence to Increase the Probability of Success in Discovery

       

Matthew Troutman, Senior Director, Pfizer

ADME SAR: The Origination, Current State and Future Possibilities, Shaped by Strategy, Science and Technology

               
 

Albert Li, President and CEO at In Vitro ADMET Laboratories LLC

Novel Hepatocyte and Enterocyte Technologies for the Evaluation of Human Drug Metabolism, Drug-Drug Interactions, and Drug Toxicity

       

Hui Zhang, Senior Principal Scientist, Pfizer

Acoustic-OPP-MS: the Next Generation BioAnalytical Platform for Drug Discovery with Ultra-High Throughput

               


Session Topics for 2018 include:

SESSION I: Developing Strategies in the ADME Discipline

SESSION II: New Technologies and Approaches in ADME Science

SESSION III: Emerging ADME Science for New Modalities

Join our Linkedin Group:

Workshops

Session I:  Developing Strategies in the ADME Discipline

Session II: New Technologies and Approaches in ADME Science

Session III: Emerging ADME Science for New Modalities

 

Registration

Click here to register for the HT-ADME conference online.

HT-ADME 2018 will take place June 21, 2018 at:

Amgen

Cambridge, MA

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy